Latest Headlines

  1. PacBio Announces Collaboration With Genomics England To Sequence Biobanked Rare Disease Samples Using HiFi Sequencing Technology 1/11/2022

    PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a collaboration with Genomics England to study PacBio’s technology for identifying genetic variants in unexplained rare disease cases.

  2. T2 Biosystems Announces The Initiation Of The T2Biothreat® Panel Clinical Trial 1/11/2022

    T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the initation of a U.S. clinical trial evaluating the performance of its T2Biothreat® Panel designed to support a submission to the U.S. Food and Drug Administration (FDA).

  3. Clinical Labs Are Integrating Tecsys' Elite™ Healthcare Software To Automate Inventory Management 1/11/2022

    Tecsys Inc. (TSX: TCS), an industry-leading supply chain management software company, today announces another important milestone for its end-to-end Elite™ Healthcare supply chain execution platform with the commercialization of its automated inventory management and management insights solution for the clinical lab environment.

  4. Technical Safety Services Significantly Expands Laboratory Service Capabilities With Acquisition Of AL-TAR 1/11/2022

    We are excited to announce that Technical Safety Services, Inc (TSS) has acquired AL-TAR Services, Inc (AL-TAR). This joining of two market leading companies creates one of the largest independent laboratory equipment service providers in the United States.

  5. Rheonix Receives FDA Clearance For Fully Automated Encompass MDx Workstation And Molecular Test For Detection Of Sexually Transmitted Infections 1/10/2022

    Rheonix Inc., an innovative leader in highly multiplexed pathogen detection, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance of its automated Encompass MDx Workstation, along with its STI TriPlex Assay and Male Urine Collection Kit for the detection of sexually transmitted infections (STI).

  6. Lucence’s LiquidHALLMARK Liquid Biopsy Assay Expands To Include cfRNA 1/10/2022

    Lucence, a precision oncology company using liquid biopsy to bring clarity to cancer care, is announcing the availability of an expanded version of its flagship LiquidHALLMARK liquid biopsy assay that includes both cell-free DNA (cfDNA) and cell-free RNA (cfRNA) profiling.

  7. Update On AffiDX SARS-CoV-2 Antigen Lateral Flow Test And Detection Of The Omicron Variant 1/10/2022

    Avacta Group plc a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer and pre|CISION platforms, provides an update on the performance of the AffiDX SARS-CoV-2 antigen lateral flow test (LFT) with the Omicron variant.

  8. NovoPath LLC Redefines Laboratory Information Systems With 2022 Release Of NovoPath 360 1/10/2022

    NovoPath LLC, a leader in laboratory information systems, today announced the release and availability of NovoPath 360, a next-generation LIS platform that provides diagnostic labs process automation, robust tools, and seamless interoperability to accurately diagnose cases faster.

  9. Indica Labs' HALO AP® Platform Achieves CE-IVD Certification For Use In Primary Diagnosis 1/10/2022

    Indica Labs, a leading provider of computational pathology software and services, is proud to announce that following ISO13485 certification, HALO AP® has received a CE Mark for use in primary diagnosis within the European Economic Area, Switzerland, and the UK.

  10. Integrating Microplate Evaporators With Liquid Handling Robots 1/7/2022

    The Ultravap Mistral family of microplate evaporators from Porvair Sciences are used in labs worldwide to remove the traditional laboratory ‘bottleneck’ of solvent evaporation from 12- to 384-well microplates and vials up to 15cm tall.